Short-term effects of denervation in the treatment of hypertension: A meta-analysis excluding drug interferences

Yimu Wang,Jingyu Liu,Lingyu Wang,Xiang Wang,Huiling Zhang,Haiyan Fang
DOI: https://doi.org/10.1097/md.0000000000040705
IF: 1.6
2024-12-01
Medicine
Abstract:Hypertension (HTN) is a global chronic noncommunicable disease that can impair the function and structure of vital organs such as the heart, brain, and kidneys. It significantly contributes to the global burden of disease and economic strain. [ 1 ] Compared to individuals with normal blood pressure, those with hypertension are at a higher risk of disease complications. [ 2 ] Meta-analysis has shown that for every 5 mm Hg reduction in systolic blood pressure, the risk of major cardiovascular events decreases by 10%. Additionally, the risks of stroke, heart failure, ischemic heart disease, and cardiovascular death are reduced by 13%, 13%, 8%, and 5%, respectively. Lowering blood pressure provides significant health benefits regardless of a patient's baseline blood pressure and whether or not they have co-morbid cardiovascular disease. [ 3 ] Therefore, active blood pressure control is essential to enhance the quality of life and improve the prognosis of hypertensive patients. Currently, lifestyle changes and medication are the cornerstones of HTN treatment. However, many patients are not adequately treated. This issue is especially pronounced in China, where approximately 1.7 million adults have hypertension, and only 7.2% of them achieve successful blood pressure control. [ 4 ] In the face of refractory hypertension, low patient compliance, medication intolerance, or resistance to lifelong medication, the search for new therapeutic approaches is particularly urgent.
medicine, general & internal
What problem does this paper attempt to address?